Lasilix Special (Furosemide)

Furosemide blocks the Na+/K+/2Cl‑ cotransporter in the thick ascending limb of the loop of Henle, preventing reabsorption of sodium, chloride, and potassium. This leads to increased urinary excretion of these ions together with water, decreasing extracellular fluid volume and blood pressure.

The appropriate dose of Lasilix Special is determined by the prescribing clinician based on the patient’s medical condition, severity of fluid overload, kidney function, and response to therapy. Dosage adjustments are made individually and should follow the prescriber’s instructions.

The safety of furosemide in pregnancy and lactation has not been definitively established. It should be used only if clearly needed and after a risk‑benefit assessment by the healthcare provider. Breastfeeding mothers should discuss potential effects with their clinician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Furosemide is a potent loop diuretic, producing a faster and greater diuretic effect than thiazide diuretics, which act on the distal tubule. Compared with other loop diuretics such as bumetanide, furosemide has a similar efficacy but may differ in dosing frequency and potency per milligram.

Lasilix Special should be stored at room temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture and direct sunlight to maintain stability and potency throughout the shelf life.

Lasilix Special is taken orally, usually with a full glass of water. It may be taken with or without food, but patients should follow the prescriber’s guidance on timing relative to meals to optimize absorption and reduce gastrointestinal discomfort.

The most serious risks include severe electrolyte disturbances (especially low potassium), dehydration leading to hypotension, ototoxicity (hearing loss or ringing), and acute kidney injury. Patients should be monitored regularly for these complications, especially during the initial treatment phase.

Lasilix Special is contraindicated in patients with anuria (no urine output), known hypersensitivity to furosemide or other sulfonamide drugs, and in those with severe electrolyte imbalance that cannot be corrected. Caution is also advised for patients with severe hepatic or renal impairment.